Breathiness and hypernasality indicating vagal nerve involvement.
Therapy Discussion
Discussion on practice speech and its relation to brain damage.
Motor Memory: Definition and significance in speech production.
Therapy approaches depend on re-establishing this memory.
Two main approaches to therapy:
Intrasystemic Reorganization: Utilizing existing speech modalities to facilitate more complex speech.
Intersystemic Reorganization: Using other preserved modalities (like gestures) to enhance speech capabilities.
Neuroplasticity and Therapy
Definition: Ability of the brain to change and adapt.
Explanation of neuroplasticity in relation to speech therapy and rehabilitation.
Key Concepts of Speech Therapy:
Intentional repetition and motor learning as part of practice for speech recovery.
Characteristics of successful therapy sessions to maximize efficiency and engagement.
Treatment Approaches for Apraxia and Dysarthria
Articulatory Kinematic Treatments: Focused on motor learning principles to improve speech functionality.
Use of Kaufman Praxis Cards:
Examples of simple to complex words to re-establish motor plans for speech.
Automatic Speech as Therapy
Use phrases that prompt automatic responses to encourage targeted speech output.
Carrier Phrases: Facilitate production of target words by providing contextual prompts.
Therapeutic Strategies for Dysarthria
Consideration of environmental factors and AAC (Augmentative and Alternative Communication) as part of holistic treatment plans.
Emphasis on effective treatment targeting.
Evidence-Based Practice in Speech Therapy
Overview of integrating current research, clinical experience, and patient preferences into treatment planning.
Critical evaluation of patient needs and environmental considerations in the treatment process.
Conclusion
Importance of adapting therapy sessions to the individual circumstances and abilities of patients to ensure therapeutic effectiveness.
Recognition of broader implications of treatment effectiveness based on patient quality of life, especially in populations with degenerative conditions or severe aphasia/apraxia.